Use of Impella Recover LP 2.5 in elective high risk percutaneous coronary intervention.
We describe a single-center experience in using the Impella Recover LP 2.5 in the setting of high-risk elective percutaneous coronary interventions. This device is placed percutaneously to support cardiac output and has a better profile than other left ventricular assist devices. Our study shows that the use of the Impella Recover LP 2.5 device is feasible, has an overall favorable safety profile, and may help prevent periprocedural and short-term complications derived from high-risk procedures.
Ferreiro
José Luis
JL
IDIBELL, Hospital Universitari de Bellvitge, Department of Cardiology, Interventional Cardiology Unit, Barcelona, Spain; University of Florida, College of Medicine-Jacksonville, Jacksonville, Florida, USA.
Gómez-Hospital
Joan Antoni
JA
IDIBELL, Hospital Universitari de Bellvitge, Department of Cardiology, Interventional Cardiology Unit, Barcelona, Spain.
Cequier
Ángel R
ÁR
IDIBELL, Hospital Universitari de Bellvitge, Department of Cardiology, Interventional Cardiology Unit, Barcelona, Spain.
Angiolillo
Dominick J
DJ
University of Florida, College of Medicine-Jacksonville, Jacksonville, Florida, USA. Electronic address: dominick.angiolillo@jax.ufl.edu.
Roura
Gerard
G
IDIBELL, Hospital Universitari de Bellvitge, Department of Cardiology, Interventional Cardiology Unit, Barcelona, Spain.
Teruel
Luis
L
IDIBELL, Hospital Universitari de Bellvitge, Department of Cardiology, Interventional Cardiology Unit, Barcelona, Spain.
Maristany
Jaume
J
IDIBELL, Hospital Universitari de Bellvitge, Department of Cardiology, Interventional Cardiology Unit, Barcelona, Spain.
Gómez-Lara
Josep
J
IDIBELL, Hospital Universitari de Bellvitge, Department of Cardiology, Interventional Cardiology Unit, Barcelona, Spain.
Jara
Francesc
F
IDIBELL, Hospital Universitari de Bellvitge, Department of Cardiology, Interventional Cardiology Unit, Barcelona, Spain.
Bass
Theodore A
TA
University of Florida, College of Medicine-Jacksonville, Jacksonville, Florida, USA.
Esplugas
Enric
E
IDIBELL, Hospital Universitari de Bellvitge, Department of Cardiology, Interventional Cardiology Unit, Barcelona, Spain.
D000368:Aged; D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects / Q000295:instrumentation* / Q000379:methods*; D003324:Coronary Artery Disease / Q000150:complications / Q000628:therapy; D017558:Elective Surgical Procedures / Q000009:adverse effects / Q000295:instrumentation* / Q000379:methods*; D005260:Female; D006353:Heart-Assist Devices / Q000009:adverse effects / Q000706:statistics & numerical data*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012042:Registries; D012307:Risk Factors